Headache Journal

67th Annual Scientific Meeting

Start Date: 06/19/2025
End Date: 06/22/2025
Location: In-person Event - Minneapolis Convention Center Minneapolis, MN

Add to Google Calendar

Poster Numbers

Below is the list of posters (poster number, title, presenting author, presenting author institution) being presented at the 67th Annual Scientific Meeting. Full abstracts will be published in the June issue of the journal, Headache®. For more information, including when to hang your poster, please visit the Abstract Presentation FAQ page.

Posters

Poster NumberTitlePresenting Author NamePresenting Author Organization
P-100Cluster Headache vs. Labor: A Comparative Perspective on Acute Pain During and After DeliverySharaf, JoudiHenry Ford Hospital
P-101Response to memantine in a patient with refractory chronic cluster headacheSchindler, EmmanuelleVA Connecticut Healthcare System
P-102The Use of Rimegepant as Acute Treatment in a Pregnant Patient with Worsening Migraine Headaches During Pregnancy: A Case ReportColon-Figueroa, PaolaUniversity of Miami, Miller School of Medicine
P-103Crippling Trigeminal Neuralgia Responsive to Lumbar PunctureOlson, MadisenCleveland Clinic
P-104Novel Missense Mutation in the NOTCH3 Gene Found in Middle-Aged Man with Persistent Headache Following Cerebral Venous Sinus ThrombosisPasmanter, NathanielMichigan State University
P-105Visual Disturbances in Migrainous Stroke: Insights from Two Patient CasesYoung, WilliamThomas Jefferson University
P-106A Case of Resolution of New Daily Persistent Headache Following Cardiac SurgeryYousaf, Muhammad Ismail KhalidVirginia Tech Carilion School of Medicine
P-107Syndrome of transient Headache and Neurological Deficits with cerebrospinal fluid Lymphocytosis (HaNDL) in an AviatorWetmore, EmmaMayo Clinic
P-108Case Report and Systematic Review of Literature on Vitamin B12 Deficiency as a Potential Contributor to Alcohol-Induced MigrainePatton, SamanthaCase Western Reserve University/University Hospitals Cleveland Medical Center
P-109Recurrence of Cerebrospinal Fluid-Venous Fistulas at Different Spinal Levels Following Transvenous Embolization or Blood/Fibrin Glue PatchingZayat, RoaaMayo Clinic
P-110Burning Mouth Syndrome Responsive to trial of Fremanezumab: A Case ReportShen, JessalynMayo Clinic Arizona
P-111Primary Stabbing Headache in association with Psychogenic Non-Epileptic SeizuresTriay, RachelCase Western Reserve University / University Hospitals Cleveland Medical Center
P-112A case of recurrent cardiac cephalalgiaBraunecker, BenjaminMayo Clinic Alix School of Medicine AZ
P-113A Curious Case of Cardiac CephalalgiaHans, AvneetUniversity of Alabama at Birmingham
P-114Aspirin failure resulting in a migrainous infarct in a young patient with a history of migraine with brain stem aura but no other significant stroke risk factorsNayak, LipikaVeterans affair
P-115Building a National Headache Medicine Research Network: The BE WELL with Migraine Champion Providers Network(TM)Wells, RebeccaAtrium Health Wake Forest Baptist
P-116When Headache Syndromes Overlap: A Diagnostic Challenge in Differentiating Hemicrania Continua from Chronic MigraineKozlova, SvetlanaSUNY Downstate Health Sciences University
P-117Headphone HeadacheSaqr, YoussraUniversity of Southern California
P-118Case Report: Atypical Onset and Recovery of Raynaud’s phenomenon with Galcanezumab with Concurrent RizatriptanZhong, WayneYale New Haven Hospital
P-119Fulminant CNS Aspergillosis Presenting as Unilateral Headache: A Case of Rapid Progression and Neurovascular ComplicationsSiddika, AyshaUniversity Of Miami Miller School of Medicine
P-120Post-dural Puncture Headaches in Patients Undergoing Recurrent Intrathecal Chemotherapy: A Case SeriesNigam, MinaliMass General Brigham
P-121Two Cases of Migraine with KCNK18 Mutation in Japanese PatientsSaigoh, KazumasaKindai University
P-122Clinical characteristics of a family with hemiplegic migraine and a novel variant in the SCN1A geneHauser Chatterjee, JessicaUniversity of Washington School of Medicine, Seattle Children's Hospital, and Neuroscience Institute, Norcliffe Foundation Center for Integrative Brain Research, Seattle Children’s Research Institute
P-123Case Report and Systematic Review of Literature on Adolescent Trigeminal NeuralgiaTriay, RachelCase Western Reserve University / University Hospitals Cleveland Medical Center
P-124Growth Hormone-Induced Chronic Migraine and Intracranial Hypertension: A Pediatric Course of Persistent Disease and Literature ReviewSiddika, AyshaUniversity Of Miami Miller School of Medicine
P-125 (Frontier)Influence of barometric pressure change in patients with migraine: A randomized, single-blind controlled studyIhara, KeikoDepartment of Neurology, Mayo Clinic
P-126Increased mortality of patients with Idiopathic intracranial hypertensionDigre, KathleenUniversity of Utah
P-127Trends Among Normal-Weight Patients with Pseudotumor Cerebri Syndrome (PTCS)Digre, KathleenUniversity of Utah
P-128Comparison of two screening test for migraine in Mexican population. Results from PREMECEF.Marfil, AlejandroUNIVERSIDAD AUTONOMA DE NUEVO LEON
P-129Prevalence and Characteristics of Headache in Acute Ischemic Stroke: A Retrospective Study in Northeast Mexico.Marfil, AlejandroUNIVERSIDAD AUTONOMA DE NUEVO LEON
P-130Disrupting the Clock: A Meta-Analysis of Night Shift Work and Migraine, Introducing Shift Work Migraine Disorder as a Novel Diagnostic EntityWoldeamanuel, Yohannes WoubishetMayo Clinic Organization
P-131Optimization and Validation of a New Score in Diagnosing Spontaneous Intracranial HypotensionXie, KexinXuanwu Hospital, Capital Medical University
P-132Headache After Hemorrhagic Stroke: A Systematic Review and Meta-analysisOng, BradleyCleveland Clinic
P-133Characterizing the Clinical Spectrum of Indomethacin-Sensitive HeadachesFensterwald, MollyDepartment of Neurology / University of California Los Angeles / Goldberg Migraine Program
P-134Rebound Intracranial Hypertension Following Treatment of Spontaneous Intracranial HypotensionZayat, RoaaMayo Clinic
P-135Advances in Neuroimaging and Pathophysiology in Idiopathic Intracranial Hypertension: A Literature ReviewQiu, EnchaoJefferson Headache Center
P-136Fourier Feature Engineering and Transformer Models for Migraine Classification Using Wearable Data from the All of Us Research ProgramKalari, Krishna RaniMAYO CLINIC ROCHESTER
P-137Importance of medical collaboration between headache specialists and gynecologists for improving the outcomes of patients with cerebral venous thrombosisKosaka, TakayukiKumamoto Medical Center
P-138Clinical Factors Associated with Delayed Diagnosis of Migraine in Patients of Songkhla Hospital, ThailandSuwanlaong, KanokratSongkhla Hospital/ Songkhla medical education center
P-139Common diagnoses and factors associated with abnormal neuroimaging in headache patients in the emergency departmentAlmalak, HassanUniversity of toronto
P-140Dizziness Diagnosis and Treatment: A Survey Assessment of Headache Healthcare ProvidersLadak, AliChildren's Hospital of Philadelphia
P-141Derealization/Depersonalization Perceptual Experiences among People with MigraineSeng, ElizabethYeshiva University & Albert Einstein College of Medicine
P-142The Effect of Endometrial Lesion Removal Surgery on Migraine Headache Frequency: Preliminary ResultsBrown, JoelWashington University in St. Louis
P-143Facial pain from internal jugular vein compression: unrecognized pathology for intractable painChan, KaylaUniversity of Minnesota
P-144Studies on Temporal Muscle Thickness and Pain Changes During Muscle Contraction in Patients with Tension-Type HeadacheFujiwara, ShunyaDepartment of Neurology, Kitasato University
P-145Efficacy and safety of rimegepant and other acute treatments in patients with migraine: an interim analysis from a national cross-sectional study in ChinaRan, YeDepartment of Neurology, Chinese PLA General Hospital; International Headache Centre, Chinese PLA General Hospital
P-146Medication Overuse in migraine patients in China: a national cross-sectional studyRan, YeDepartment of Neurology, Chinese PLA General Hospital; International Headache Centre, Chinese PLA General Hospital
P-147What is the Importance of Pain Behaviors in Headache Patients? Divergent Perceptions of General Neurology and Headache SpecialistsMedrea, IoanaUniversity of Toronto
P-148Migraine as a Risk Factor for Primary Open-Angle Glaucoma: An Updated Systematic Review and Meta-AnalysisParuchuri, AmithAll India Institute Of Medical Sciences, New Delhi
P-149A Literature Review of the Effect of Video Games on Migraine and Other HeadachesRosen, NoahNorthwell
P-150Does Missing Information Necessary Implies Misdiagnosis in ICHD3?Zhang, PengfeiBeth Israel Deaconess Medical Center/Harvard Medical School
P-152Classifying Primary Headache Disorders Through Secondary Headache DifferentialsZhang, PengfeiBeth Israel Deaconess Medical Center/Harvard Medical School
P-153Title: An Interdisciplinary Approach to Medication Overuse Headache: A Case StudySaqr, YoussraUniversity of Southern California Headache Center
P-154Case-Control Study of Headache Burden and Associated Symptoms in Youth With and Without Generalized Joint Hypermobility and Autonomic DysfunctionMarshall, AlisonChildren's Hospital of Philadelphia
P-155Cervical Pain and Musculoskeletal Dysfunction in Children and Adolescents Diagnosed with Migraine: a Cross-Sectional StudyPriuli, JaquelineUniversity of São Paulo
P-156Prevalence of Abnormal Brain MRI Findings in Pediatric Migraine: A Retrospective ReviewLorah, VictoriaBarrow Neurological Institute at Phoenix Children's
P-157Tachysensia and Migraine: A Review of the Literature and Forum AnalysisBellacicco, NicholasRutgers New Jersey Medical School
P-158Finding a way to speak for those who cannot express their pain: barriers to headache care for the patient with developmental delays\nPart 1: Diagnosis and Treatment of HeadacheMcVige, JenniferDent Neurologic Institute
P-159Psychedelic Use in Migraine and Cluster Headache Patients Within a Subset of the Cross-Sectional Canadian Psychedelic Survey.Baron, EricCleveland Clinic Neurological Institute, Center for Headache and Pain
P-160MIgRane Related Outcomes Registry (MIRROR)Cook, CalliEmory University School of Nursing
P-161Chronic Migraine in México: First clinical descriptionMarfil, AlejandroUNIVERSIDAD AUTONOMA DE NUEVO LEON
P-162Childhood anxiety and depression, parental mental health, and the development of migraine in adolescence: findings from a prospective longitudinal Canadian birth cohort studyOrr, SerenaUniversity of Calgary
P-163Chronic daily/near daily headache: study of impact on work disability in a Mexican population. Results from PREMECEFMarfil, AlejandroUNIVERSIDAD AUTONOMA DE NUEVO LEON
P-164Neuromodulation Device Usage Across VA Headache PatientsHans, AvneetUniversity of Alabama at Birmingham
P-165Headache prevalence in healthcare professionals in a third level hospitalMarfil, AlejandroUNIVERSIDAD AUTONOMA DE NUEVO LEON
P-166The association between sleep duration with migraine frequency, disability and perceived stress in the Headache Assessment via a Digital platform in United States (HeAD-US) StudyVgontzas, AngelikiHarvard Medical School, Brigham and Women's Hospital
P-167Beyond Atrial Shunt-A Comprehensive Comparison of Cardiac Anatomical and Physiological Abnormalities in Migraine With and Without Aura From A Detailed Echocardiography RegistryYang, Ping-HaoMayo Clinic
P-168Investigating most bothersome symptom consistency in selection over repeated self-reported migraine days: Results of the MiCOAS StudyMcGinley, JamesVector Psychometric Group, LLC
P-170Incidence of Concussion and Post Concussion Syndrome in Professional WrestlingBondoc, ChristopherComplete Neurological Care
P-171Higher Atrial Fibrillation Probability and Delta Age Computed by Artificial Intelligence-Electrocardiogram Models Predict Higher Risk of Cardiovascular Events in Patients with MigraineYang, Ping-HaoMayo Clinic
P-172Long-term particulate matter exposure and the risk of migraine: results from the China Health and Retirement Longitudinal Study (CHARLS)Zhang, YurongThe First Affiliated Hospital of Xi’an Jiaotong University
P-173The Long-Term Impact of COVID-19 on Admissions for Migraine with DHE: a Descriptive AnalysisLim, TaehongStanford University
P-174Impact of Smoking on Cluster Headache: Clinical Characteristics, Autonomic Manifestations, and Treatment Response in 129 CasesImai, NoboruJapanese Red Cross Shizuoka Hospital
P-175Changes in Headache Days and Acute Medication Adherence over 3 Months of Diary TrackingSeng, ElizabethYeshiva University & Albert Einstein College of Medicine
P-176Post-Traumatic Headaches in the Long-Term Traumatic Injury Outcomes and Resource Utilization (LTIORU) Study in Military and Veteran Population.Licona, NytziaHCOE/VAPAHCS
P-177Migraine and stroke risk in middle and older age: the Reasons for Geographic and Racial Differences in Stroke cohortSprouse-Blum, AdamUniversity of Vermont
P-178Comparison of Migraine with and without Aura in a Cohort of 31,715 Patients: Disease Characteristics and Response to Remote Electrical Neuromodulation (REN) TreatmentMonteith, TeshamaeMiller School of Medicine, University of Miami
P-179Detailed Migraine Symptoms: Patterns and Sex-related Differences in Patients at a Tertiary Headache CenterModi, TanishMayo Clinic
P-180Burn Pit Exposure and Headache among US Veterans: Headache Phenotypes and OutcomesLaferriere, CassandraHeadache Center of Excellence, VA Connecticut
P-181Migraine and the risk of stroke and heart disease: a Chinese population-based cohort studyZhang, YurongThe First Affiliated Hospital of Xi’an Jiaotong University
P-182Associations of Lisinopril/Candesartan, Anti-CGRP Treatments vs. Topiramate on Cardiovascular Outcomes in Patients with Migraine: Target Trials Emulation from the Veterans Health AdministrationWang, KaichengVHA Headache Centers of Excellence
P-183Stigma intervention and self-advocacy education for people with migraine: a digital ethnographic studyBuse, DawnAlbert Einstein College of Medicine, Department of Neurology
P-184Responsiveness of the Brazilian-Portuguese versions of Headache Impact Test and Headache Disability Inventory for migraine patientsPinheiro-Araujo, CarinaRibeirão Preto Medical School
P-185Understanding the educational needs of cluster headache patientsFrerichs, LindsayBarrow Neurological Institute
P-186Time to Last MyHealth Chart Access as a Marker for Healthcare Utilization in Migraine: a Comparative AnalysisZhu, WilliamStanford Health Care
P-187Air Quality and Migraine Risk in the All of Us Research ProgramHsu, Pei-NingRush University Medical Center
P-188US Veterans’ Experience of Toxic Exposures During Military Service and their Perspectives on Contribution to Headache Symptoms: A Qualitative Study from the Veterans Health Administration Headache Centers of ExcellenceGoldman, RobertaWarren Alpert Medical School of Brown University and VHA Headache Centers of Excellence
P-189VHA National TeleNeurology Program vs. Community Care: a Migraine Pilot ProjectCrisan, ElenaNational TeleNeurology Program, Corporal Michael J Crescenz VAMC; Jesse Brown VAMC
P-190Local audit of use of opioids in patients with headaches in secondary careTanda, OlgaGreat Western Hospital NHS Foundation Trust
P-191Migraine and cognitive function: a Chinese population-based cohort studyZhang, PanpanThe First Affiliated Hospital of Xi’an Jiaotong University
P-192Asynchronous Telemedicine's Role in Expanding Access to Evidence-Based Migraine CareCrystal, SaraKMG; NY Headache Center
P-193Proof of Concept -Implementing the AHS 2020 Advisory Board Recommendations for Addressing the Crisis of Migraine in Primary CareFriedenberg, ScottGeisinger
P-194Predictors of Acute Treatment Response in Migraine: The Headache Assessment Via Digital Platform in United States (Head-US) studyTeichrow, DevinUniversity of California, Irvine
P-195Improving Atherosclerotic Cardiovascular Disease Risk Scores in Individuals with MigraineDumkrieger, GinaMayo Clinic
P-196Factors influencing the interictal executive function in migraine.Shibata, MamoruDepartment of Neurology, Tokyo Dental College Ichikawa General Hospital
P-197The effect of menopausal hormone therapy on headache and migraine severity: results from the Women’s Health Initiative Hormone Therapy Clinical TrialsCrowe, HollyBrigham and Women's Hospital/Harvard Medical School
P-198The Migraine Clinical Outcome Assessment System (MiCOAS) measures: Emotional FunctioningHouts, CarrieVector Psychometric Group, LLC
P-200Diagnostic and Treatment Disparities in Chronic Post-Traumatic Headache: Real-World Data from a Large Academic Medical CenterArnold, KyleUniversity of Washington
P-201NIH Impact-Adjusted Funding Ratio for Migraine has not Significantly Changed in Fifteen YearsNofar, JustinThomas Jefferson University
P-202Oxygen prescription and continuous use among US Veterans with medically diagnosed cluster headacheSchindler, EmmanuelleVA Connecticut Healthcare System
P-203Religion and Migraine: Risks, benefits and other associations. A literature review and discussionRosen, NoahNorthwell
P-204Disparities in Inpatient Dihydroergotamine Administration in Pediatric Patients with Headache at the Children's Hospital of PhiladelphiaSzperka, Christina L.Children’s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania
P-206Pediatric migraine and risk of young adult depression and anxiety in the Growing Up Today StudyCrowe, HollyBrigham and Women's Hospital/Harvard Medical School
P-207Comparing baseline demographic and clinical characteristics from a longitudinal observational study examining headache in transfeminine/gender diverse youth and cisgender male peersHemond, RyUniversity of Colorado School of Medicine
P-208Optimizing Headache Management in Primary Care: An Evidence Based Quality Improvement PlanFikrat, MakaylaUniversity of Vermont
P-209Bridging the Global Gap: Evaluating Headache Medicine Practices Among Laotian Healthcare ProvidersHeng, AllysonUniversity of Alabama at Birmingham
P-210Veterans Deployed with Burn Pit Exposure, Headache Disease, and Healthcare Trajectories: A mixed-methods evaluation.Damush, TeresaVHA Headache Centers of Excellence (HCoE), Indiana University School of Medicine
P-211FHTH: Find the Headache, Treat the Headache – Diagnosis and Management of Headache in Acute, a re-auditTanda, OlgaGreat Western Hospital NHS Foundation Trust
P-212Uncovering Barriers and Disparities in Migraine Care Among Diverse and Underserved CommunitiesAilani, JessicaMedStar Georgetown University Hospital
P-213Living with Cluster Headache – Reflections from U.S. Veterans: A Qualitative Study from the Veterans Health AdministrationSchantz, KarolinaVector Psychometric Group, LLC
P-214Development of a User-Friendly, Graphical Interface for a REDCap Headache Diary: Enhancing Patient Engagement and Research Integration Through Dashboard-Driven FeedbackSmith, DaniMayo Clinic Arizona
P-215Applying Group Organization Scoring to Measure and Monitor Multidisciplinary Facility-Level Headache Care for VHA Headache Centers of ExcellenceBaird, SeanVHA Headache Centers of Excellence
P-216International Cluster Headache outreach expert opinion webinar using interdisciplinary approachMariana, CiobanuVanderbilt University Medical Center, Monroe Carell Jr Children's Hospital at Vanderbilt
P-217Needs Assessment Study for the Student Neurology Ambulatory Preceptorship (SNAP) Headache ClinicRobbins, MatthewWeill Cornell Medicine
P-218Using Interprofessional Education (IPE) Approach and “The 3 Item Erwin Test for Cluster Headache” to Reduce Diagnostic Errors & DelayGibb, VeraUniversity of Texas Medical Branch at Galveston
P-219Headache Home Monitoring Program: Enhancing Patient & Physician CommunicationEberhard, SpencerPhoenix Children's Hosptial
P-221Investigating the Role of Perineuronal Nets in Migraine Associated Cognitive DysfunctionKotiyal, AkhileshWashington University
P-222Effects of Olcegepant, Sumatriptan, and Ibuprofen on Migraine-Like Behavior Induced by Repetitive Restraint Stress in MiceNematgorgani, ShivaUniversity of Texas at Dallas
P-223 (Frontier)The effect of selective adenosine A3 receptor (A3AR) agonism on migraine-like dural-responsive trigeminocervical neuronsGamal-Eltrabily, MohammedSchool of Dentistry, University of Maryland Baltimore
P-224Sex-dependent effects of stress on trigeminocervical sensitization and migraine-like neuronal activation in ratsSALINAS ABARCA, ANASchool of Dentistry, University of Maryland Baltimore
P-225Targeting the sphingosine-1-phosphate receptor 1 (S1PR1) pathway in preclinical models of migraine-like periorbital hypersensitivityAkerman, SimonSchool of Dentistry, University of Maryland Baltimore
P-226CGRP Antibodies Exacerbate Stroke Outcomes Following Blood-Brain Barrier OpeningJin, XuyanMassachusetts General Hospital
P-227Small-molecule CGRP antagonist atogepant does not alter cortical spreading depression susceptibility in ratsJin, XuyanMassachusetts General Hospital
P-228Transcriptome-level Identification of PLA2G7 Involved in the Choroid Plexus of Chronic Migraine Model Induced by Recurrent Nitroglycerin.Fonteh, AlfredHMRI
P-229Oral Atogepant Mitigates Spreading Depolarization–Induced Pain and Anxiety Behavior in MiceKaya, Melih ZekiMassachusetts General Hospital
P-230Ibuprofen inhibits post-cortical spreading depolarization oligemiaMorais, AndreiaMassachusetts General Hospital
P-231 (Frontier)Investigating the Role of Fremanezumab in Cortical Spreading Depression and Migraine PathophysiologyJin, XuyanMassachusetts General Hospital
P-232Hypothyroidism Decreases Susceptibility to Cortical Spreading Depression in RatsZhai, QinglingMassachusetts General Hospital
P-233Pharmacokinetic (PK) and Tissue Distribution Study in Rats for Assessment of Rapid, Non-addictive Headache Pain TreatmentCook, JasonOlfax Medical
P-234Real world effectiveness and tolerability of rimegepant for the acute treatment of migraine in triptan non-responders: A case seriesKang, Wenyan1.Ruijin Hospital Affiliated Shanghai Jiao Tong University School of Medicine 2.Ruijin-Hainan hospital Shanghai Affiliated Jiao Tong University School of Medicine (Hainan Boao Research Hospotal)
P-235Observational study of the effect of a Bupivacaine Diluent in Botulinum Toxin Injections to reduce Post-Procedural Headache in patients with Chronic MigraineOlson, MadisenCleveland Clinic
P-236Veteran Satisfaction with Biofeedback Training for HeadacheGrinberg, AmyHeadache Center of Excellence
P-237Efficacy of preventive treatment for episodic migraine with, versus without, pulsatile painMarfil, AlejandroUNIVERSIDAD AUTONOMA DE NUEVO LEON
P-238The role of manual therapy and cupping in managing post-traumatic headaches, dizziness, and neck pain in a chronic traumatic brain injury patient.Medlej, CharbelDepartment of Veterans Affairs / Neurology/ Headache Center of Excellence
P-239Efficacy and Safety of Once-daily Rimegepant 75 mg Orally Disintegrating Tablet for the Short-term Preventive Treatment of Fasting-related HeadacheAlsaadi, TaoufikAmerican Center for Psychiatry and Neurology
P-240Biofeedback-Assisted Relaxation Delivered by Physical Therapists for Patients with Migraine: A Pilot Randomized Controlled TrialMinen, MiaDepartments of Neurology and Population Health, NYU Langone Health
P-241Real World Evidence for Risk-Averse Behavior in the Prescribing of Calcitonin Gene-Related Peptide Monoclonal Antibodies by Headache Specialists for the Prevention of Migraine: a Retrospective, Cohort StudyNandyala, ArathiWeill Cornell Medicine
P-242Epidural blood patching in patients with spinal meningeal diverticula, low Bern score, and orthostatic headache syndromeZayat, RoaaMayo Clinic
P-243Ubrogepant Efficacy and Safety in the Acute Treatment of Migraine in Patients Currently Treated with CGRP Monoclonal AntibodiesTorphy, BradleyChicago Headache Center & Research Institute
P-244Real World Survey of Patient-Reported Gepant Acute Responses and UsagesGhosh, ShreyaThomas Jefferson University
P-245Individualized Migraine Treatment: Integrating clinical knowledge and machine learningBabaei, MahsaStanford University
P-246A biomechanical approach to headache associated with traumatic brain injury using osteopathic manipulation: a proof of concept trialAlexander, JoshuaScripps Clinic
P-247CACS: Clinical Advantages of cGRPi switch, a retrospective observational study.Tanda, OlgaGreat Western Hospital NHS Foundation Trust
P-248Effects of Injectable Calcitonin Gene-Related Peptide-Antagonists on Migraine-Associated Cost BurdenChappell, JonathanTuscaloosa VA Medical Center
P-249Utilization and Perceived Benefit of Alpha Stim in Service Members and Veterans with Traumatic Brain InjurySkop, KarenJames A Haley Veterans' Hospital
P-250The Impact of Surgical Repair of Facial Trauma on the Incidence and Severity of Post-Traumatic Migraines: A Meta-AnalysisKareddy, AbhinavUniversity of Virginia School of Medicine
P-251Prospective observational study of three-month response to eCOT-NS device in patients with headacheRobblee, JenniferBarrow Neurological Institute
P-252Effect of Intravenous Magnesium on Post-Concussion SyndromeSaqr, YoussraUniversity of Southern California
P-253Efficacy of Pulsed Radiofrequency Compared to Nerve Block for Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsAlvarez, DianaInstituto Nacional de Cancerología, Colombia
P-254Efficacy of Music and Sound Therapy in Headache Management: A Systematic ReviewHeng, AllysonUniversity of Alabama at Birmingham
P-255Predictive Characteristics of Pain Relief After Great Occipital Nerve Block Treatment in Migraine and Chronic Headache PatientsSuwanlaong, KanokratSongkhla Hospital/ Songkhla medical education center
P-256Dual Calcitonin Gene-Related Peptide Antagonists for Chronic Migraine PreventionTo, JasonUniversity of Vermont Medical Center
P-257Use of nVNS and sTMS in Veterans with Chronic Headache and Concurrent Psychiatric conditionsThiam, MelindaNew Mexico Veterans Health Care Services
P-258Treatment Patterns and Timing of CGRP-mAbs Switching in Thailand: A Retrospective Analysis in Southeast AsiaANUKOOLWITTAYA, PRAKITChulalongkorn Headache and Orofacial Pain (CHOP) Service and Research Group, Division of Neurology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
P-259Real-life use of rimegepant in the acute treatment of migraine among Chinese adults:Interim analysis of a multicenter, prospective, observational studyRan, YeDepartment of Neurology, Chinese PLA General Hospital; International Headache Centre, Chinese PLA General Hospital
P-260Low Glutamate Diet as a Potential Therapy for Headache in Veterans with Gulf War Illness: Preliminary Clinical Trial ResultsMartami, FahimehAmerican University
P-261 (Frontier)Real-World Outcomes of Zavegepant Use in a Tertiary Care Setting using Migraine Treatment Optimization Questionnaire-5 (MTOQ-5)Dunn, EricCleveland Clinic
P-262A Cross-Sectional Analysis of Nonpharmacologic Migraine Trials Registered on ClinicalTrials.govMinen, MiaDepartments of Neurology and Population Health, NYU Langone Health
P-263Can Mindfulness Target Patients with Comorbid Migraine and Depression?: A Narrative ReviewAdam, EllieAtrium Health Wake Forest Baptist and Cincinnati Children's Hospital Medical Center
P-264The Relationship Between Dance Interventions and Headache: A Narrative ReviewVaidya, ShivaniAtrium Wake Forest University
P-265Non-Pharmacological Therapies in Migraine Treatment: Evaluating the Value of Osteopathic Manipulative TreatmentMalhotra, SoumyaNova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine
P-266K9 Patriot PAWS of Valor: Service Dogs as Therapeutic Partners for Veterans with PTSD and MigraineThiam, MelindaNew Mexico Veterans Health Care Services
P-267The Earliest Descriptions and Treatments for Migraine: From the Dawn of Civilization to GalenSajan, JensineNorthwell
P-268Coenzyme Q10 Supplementation Correlated with Resolution of New Daily Persistent HeadacheLangdon, RaquelChildren's National Hospital
P-269Oral magnesium reduces headache days but not headache intensity, duration, or impact in youth with migraineWingert, TammieChildren's Mercy Hospitals
P-270Aprepitant for Primary Nausea Control for Pediatric Patients during Repetitive Dihydroergotamine InfusionsPavitt, SaraUniversity of Texas at Austin
P-271Prescription Patterns for Preventive Medications in Pediatric Chronic Migraine, Post-Traumatic Headache and Patients with a Dual-DiagnosisAfrick, BenjaminStanford Healthcare
P-272Memantine use in Adolescent Migraine: A Retrospective StudyYousaf, Muhammad Ismail KhalidVirginia Tech Carilion School of Medicine
P-273Investigating Zonisamide Prophylaxis for Pediatric Migraine Patients, A Retrospective AnalysisKelley, AnisaNorthwestern University Feinberg School of Medicine
P-274A retrospective analysis of the most bothersome dysautonomia symptoms in pediatric and adolescent patients with migraine and effectiveness of propranolol vs CGRP antagonists on headache preventionGunduz, Muhammed TalhaBaylor College of Medicine/Texas Children's Hospital
P-275Peripheral Nerve Block in the Treatment of Pediatric Headache and Neuralgia: A Scoping ReviewSlettvet, KatherineSeattle Children’s Hospital, Department of Pediatric Neurology
P-276Memantine: From Dementia to Post-Traumatic HeadacheShane, BradleyUCLA
P-277 (Frontier)Remote Electrical Neuromodulation in the Treatment of Medication Overuse HeadacheMadhok, SehajvirCincinnati Children's Hospital Medical Center
P-278 (Frontier)Simultaneous OnabotulinumtoxinA and Calcitonin Gene-Related Peptide-Blocking Therapy in Refractory Headache in AdolescentsRospigliosi, DeliaChildren's Hospital of Philadelphia
P-279Safety of OnabotulinumtoxinA Administration During Second and Third Trimester of Pregnancy and LactationKhan, FarahCleveland Clinic Foundation
P-280A Real World, Retrospective Case Series of the Treatment of Suspected Pediatric Intracranial HypotensionRosenthal, ScottUniversity of Colorado School of Medicine/Children's Hospital Colorado
P-281Using interest holder perspectives to guide iterative adaptations of a virtual mindfulness-based group intervention for adolescents with migraineClementi, MichelleChildren's Hospital Colorado
P-282Development and Preliminary Feasibility and Acceptability of a Novel Intervention for Parents of Youth with MigraineTurnage, CathleenOregon Health & Science University (OHSU)
P-283Impaired Cerebral Oxygenation and Autonomic Dysregulation During Exercise in MigraineFaria de Oliveira, MayronLyon College
P-284Using MRI-based morphometrics to compare ictal versus interictal brain volumes in status migrainosusRobblee, JenniferBarrow Neurological Institute
P-285Longitudinal Analysis of Pain-Induced Brain Activations in Post-Traumatic HeadacheKu, DohyunGeorgia Tech
P-286Altered intra-network functional connectivity predicts the 6-month prognosis in patients with medication overuse headache: A case-control studyLi, ChanglingDepartment of Neurology, West China Hospital of Sichuan University.
P-287Default mode network dysfunction and cognitive impairment in patients with medication overuse headache: A cross-sectional studyLi, ChanglingDepartment of Neurology, West China Hospital of Sichuan University.
P-288Post-Prandial Glucose Dysregulation and Glycemic Phenotyping in Chronic MigraineBills, KyleThe Noorda College of Osteopathic Medicine
P-289Association between peripheral inflammation biomarkers and clinical phenotypes in patients with medication overuse headache: a cross-sectional studyLi, ChanglingDepartment of Neurology, West China Hospital of Sichuan University.
P-290Relationship between Cycling of Traditional Oral Generic Preventive Medications and Patient-Reported Outcomes: US Results from the Chronic Migraine Epidemiology and Outcomes – International StudyBuse, DawnAbbVie
P-291Opioid Use, Disability, and Cognition in Migraine: Multi-Country Results From the Chronic Migraine Epidemiology and Outcomes – International StudyContreras-De Lama, JanetteAbbVie
P-292Impact of Triptan Insufficient Response on Medication Use, Health Care Utilization, and Costs: A Retrospective Claims StudyAilani, JessicaAbbVie
P-293Migraine Progression and Persistence: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) StudyLipton, RichardThe Saul R. Korey Department of Neurology, Department of Psychiatry and Behavioral Science, and Department of Epidemiology and Population Health, Montefiore Headache Centre, Albert Einstein College of Medicine, New York, NY, USA
P-294Pharmacotherapy Treatment Patterns in Veteran Patients with MigraineAlvarez, CarlosTexas Tech Univ HSC Jerry H. Hodge School of Pharmacy
P-295Real-world Switch Rates of Injectable Migraine Preventive Therapies in Patients with Chronic MigraineAhmadyar, GinaAbbVie
P-296Evaluation of Unmet Needs and Quality-of-Care Indicators Among Patients with Migraine in the United States: 2021–2022Martin, VincentUniversity of Cincinnati
P-297Eptinezumab and patient education in chronic migraine and medication-overuse headache: Results from the randomized, placebo-controlled RESOLUTION trialTepper, Stewart J.New England Institute for Neurology and Headache, Stamford, CT, USA
P-298CT-132, a Safe and Effective Digital Therapeutic Complement to All Pharmacotherapy for Adults With Episodic Migraine: An Integrated AnalysisLakhan, ShaheenClick Therapeutics Inc
P-299Long-term Improvements Following ≥50% Migraine Response to Eptinezumab Treatment in Participants With Migraine: Post Hoc Analysis of the DELIVER TrialAilani, JessicaMedStar Georgetown University Hospital
P-300Interim analysis of CONFIDENCE: A prospective observational study with acute treatment of rimegepant ODT on consistency, satisfaction and tolerability of treatment in the real worldAbraham, LucyPfizer R&D UK Ltd.
P-301Long-Term Persistence of OnabotulinumtoxinA Versus Calcitonin Gene-Related Peptide Monoclonal Antibodies in New Initiators With Chronic MigraineAhmadyar, GinaAbbVie
P-302Impact of Atogepant on Migraine Headache Severity for the Preventive Treatment of Episodic Migraine: A Post-Hoc Analysis of the 12-Week ADVANCE and 52-Week Open-Label TrialsReda, IvonnaAbbVie
P-303Pregnancy outcomes following exposure to galcanezumab: review of cases from the galcanezumab clinical trialsMartyn, FionaEli Lilly and Company, Indianapolis, IN, USA
P-304Mi-Helper Transnasal Cooling for Acute Migraine Treatment: A prospective, double-blind, randomized, sham-controlled, decentralized dosing studyMays, MaryAnnCleveland Clinic
P-305DHE Plasma Concentration and Clinical Response Relationship – An In-office PK-PD StudyAlbrecht, DetlefSatsuma Pharmaceuticals, Inc.
P-306Impact of Atogepant on Activity Limitations Stratified by Patient Global Impression of Change Responders and Non-Responders: Post Hoc Analyses of Three Pivotal TrialsLipton, RichardThe Saul R. Korey Department of Neurology, Department of Psychiatry and Behavioral Science, and Department of Epidemiology and Population Health, Montefiore Headache Centre, Albert Einstein College of Medicine, New York, NY, USA
P-307Strong CYP3A4 Inhibitor Itraconazole does not cause clinically relevant interactions with STS101 (nasal Dihydroergotamine powder)Albrecht, DetlefSatsuma Pharmaceuticals, Inc.
P-308Efficacy and safety of eptinezumab in chronic migraine: A randomized placebo-controlled trial in a predominantly Asian populationEttrup, AndersH. Lundbeck A/S
P-309STS101 Use Reduces Migraine Frequency Over TimeTepper, Stewart J.New England Institute for Neurology and Headache, Stamford, CT, USA
P-310STS101 (Dihydroergotamine Nasal Powder) Shows Benefit on the Resolution of Cardinal Migraine Symptoms Photophobia, Phonophobia, and Nausea: Results from the Long-Term Phase 3 Open-Label ASCEND StudyStarling, AmaalMayo Clinic Arizona, Scottsdale, AZ, USA
P-311CT-132, an Investigational Prescription Digital Therapeutic, Improves Quality of Life and Reduces Migraine-Related Disability in Patients With Episodic Migraine Receiving Acute and Preventive Migraine Prescription MedicationsSnipes, CassandraClick Therapeutics Inc
P-312Number Needed to Treat Analysis of Atogepant Compared to Rimegepant for the Preventive Treatment of Episodic Migraine in Japanese and Global ParticipantsTakeshima, TakaoHeadache Center and Department of Neurology, Tominaga Hospital
P-313Real-World Effectiveness, Treatment Optimization, and Satisfaction of Ubrogepant for the Acute Treatment of Migraine in Individuals Taking Atogepant for the Preventive Treatment of Migraine: Results from the COURAGE II StudyNahas, StephanieThomas Jefferson University
P-314Long-term safety and tolerability of zavegepant 10 mg nasal spray by dosing frequency: post-hoc analysis of a phase 2/3 open-label studyVieira, JulioNuvance Health Neuroscience Institute / Albert Einstein College of Medicine
P-315Atogepant Demonstrates Greater Improvement in Function Using the Activity Impairment in Migraine-Diary (AIM-D) During Interictal Days: Post-Hoc Analysis From the PROGRESS Chronic Migraine TrialLipton, RichardThe Saul R. Korey Department of Neurology, Department of Psychiatry and Behavioral Science, and Department of Epidemiology and Population Health, Montefiore Headache Centre, Albert Einstein College of Medicine, New York, NY, USA
P-316Efficacy of Symbravo® (MoSEIC™ meloxicam and rizatriptan) by baseline migraine-associated disability: post-hoc analysis of the INTERCEPT trialTepper, Stewart J.New England Institute for Neurology and Headache, Stamford, CT, USA
P-317A Longitudinal Study on the Onset and Sustained Benefits of OnabotulinumtoxinA: Insights from the PREEMPT TrialsMcGinley, JimAbbVie
P-318Hypertension and rimegepant use: a review of clinical and postmarketing safety dataYang, JiyuePfizer Inc
P-319Impact of Participant-reported ≥75% Increase in Good Days/Month on Migraine Symptoms, Quality of Life, and Brain Fog: Results of the REVIEW Real-world Study of Adults With Chronic Migraine Treated with EptinezumabArgoff, CharlesAlbany Medical Center
P-320Sustained Reductions in Monthly Headache Days with Long-Term Eptinezumab Treatment for Chronic Migraine: Post-Hoc Analysis of the Phase 3 PREVAIL StudyStarling, AmaalMayo Clinic Arizona, Scottsdale, AZ, USA
P-321First in human study to evaluate pharmacokinetics, safety and tolerability of a novel in-development dihydroergotamine mesylate (DHE) inhalation powder delivered via a multidose dry powder inhaler (DPI)Goyal, PankajAspeya Switzerland SA
P-322Remote Electrical Neuromodulation (REN) Shows No Tachyphylaxis and Consistent Efficacy Over Three Years of TreatmentNahas, StephanieThomas Jefferson University
P-323Economic Impact of Early Vs. Late Initiation of Atogepant for The Preventive Treatment of MigraineGandhi, PranavAbbVie
P-324Milk and Plasma Pharmacokinetics of Single-Dose Atogepant in Healthy Lactating WomenBoinpally, RameshAbbVie
P-325Evaluation of Patients Treated with Orphenadrine-Aspirin-Caffeine Combination Tablets for the Management of HeadachesCroxton, DaneGalt Pharmaceuticals
P-326Early Intervention with Remote Electrical Neuromodulation (REN) Improves Efficacy of Acute Treatment of MigraineStark-Inbar, AlitTheranica
P-327Long-Term Safety and Discontinuation for Rimegepant Versus Triptans: A Matching-Adjusted Indirect ComparisonJenkins, AaronPfizer Ltd
P-328Network Meta-Analysis Comparing Efficacy and Safety Outcomes of Atogepant, Rimegepant, and Galcanezumab in Patients with Episodic Migraine After Including CHALLENGE-MIG TrialGandhi, PranavAbbVie
P-329Real-world Use and Patient Profiles of Rimegepant for Short-term Prevention among Patients with Migraine: Insights from a US Patient SurveyMonteith, TeshamaeMiller School of Medicine, University of Miami
P-330Long-term effects of Symbravo® (MoSEIC™ meloxicam and rizatriptan) on headache burden and quality of life: results of the MOVEMENT trialLipton, RichardThe Saul R. Korey Department of Neurology, Department of Psychiatry and Behavioral Science, and Department of Epidemiology and Population Health, Montefiore Headache Centre, Albert Einstein College of Medicine, New York, NY, USA
P-331A Phase 1 Study of the Breast Milk and Plasma Pharmacokinetics of Zavegepant 10 mg Intranasal Dose in Healthy Lactating WomenJakate, AbhijeetPfizer Inc
P-332Characteristics and Eptinezumab Infusion Experience in Participants in Whom ≥1 Prior Preventive anti-CGRP Treatment had Failed: Interim Results of an Ongoing Real-world StudyStarling, AmaalMayo Clinic Arizona, Scottsdale, AZ, USA
P-333Retention Rates Across Clinical Trials of Anti-CGRP Monoclonal Antibodies for Migraine PreventionBlumenfeld, AndrewThe Los Angeles Headache Center, Los Angeles, CA, USA; The San Diego Headache Center, San Diego, CA, USA
P-334A Retrospective Cohort Study Comparing Persistence Between Rimegepant and lasmiditan for the Acute Treatment of Migraine in the USJenkins, AaronPfizer Ltd
P-335Treatment With Fremanezumab Attenuates the Association Between Weather and Headache in Participants With Episodic Migraine: a Post-Hoc Analysis of the HALO-EM and HALO-LTS StudiesCohen, FredDepartment of Neurology, Icahn School of Medicine at Mount Sinai; Department of Neurology, Icahn School of Medicine at Mount Sinai
P-336Subgroup analysis of celecoxib oral solution by sex in the acute treatment of migraineLipton, RichardThe Saul R. Korey Department of Neurology, Department of Psychiatry and Behavioral Science, and Department of Epidemiology and Population Health, Montefiore Headache Centre, Albert Einstein College of Medicine, New York, NY, USA
P-337Estimating the distribution of prior prophylaxis treatment failures in episodic migraine (EM) prophylaxis trialsJenkins, AaronPfizer Ltd
P-338 (Frontier)The Protective Effects of NAD+ Precursor in a Preclinical Model of Chronic MigraineAwad-Igabria, yaseenThe Department of Anesthesiology, Washington University
P-339 (Frontier)Mechanism of glucocorticoids-mediated stress-induced migraineHu, Ya-YuUniversity of Texas at Dallas
P-340 (Frontier)Therapeutic Potential of Low-Dose IL-2 in Stress-Triggered MigraineSimoes, RoliWashington University in St. Louis
P-341Eptinezumab Treatment was Associated with Longer Interictal Periods and Larger Improvements in Quality of Life in Participants With Migraine for Whom 2-4 Prior Preventive Treatments had Failed: A Post Hoc Analysis of the DELIVER TrialTepper, Stewart J.New England Institute for Neurology and Headache, Stamford, CT, USA

Late-breaking Posters

Poster NumberTitlePresenting Author NamePresenting Author Organization
P-342Provider type influence on migraine preventive treatment and therapy progression timelines within the Veteran’s Health AdministrationAlvarez, CarlosTexas Tech Univ HSC Jerry H. Hodge School of Pharmacy
P-343Weight Loss With Atogepant in Participants With Migraine and Overweight or Obesity: Interim Analysis of a Phase 3, Multicenter, Open-Label, 156-Week Extension StudyPeterlin, B. LeePennsylvania Headache Center
P-344Comparative Efficacy of Over-the-Counter versus Oral Prescription Medications for Acute Treatment of Episodic Migraine – A Meta-AnalysisMitra, AshokeHaleon
P-345Evaluating the Effectiveness and Safety of Fremanezumab in Adults With Migraine and Obesity: A Phase 4 Retrospective Chart Review StudyOrtega, MarioTeva Branded Pharmaceutical Products R&D, Inc.
P-346A post hoc subgroup analysis in migraine aura from the TEAM (a phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute Treatment of Migraine) studyKuruvilla, DeenaBrain Health Institute
P-347Progressive Cervical Degeneration and Occipital Neuralgia in a Patient with Parkinson’s Disease and Cervical Dystonia: A Case ReportAlvarez, DianaInstituto Nacional de Cancerología, Colombia
P-348Outcome of ultrafast CT myelography: Success rate, site of leak, and comparison with MR myelographyJeong, Hoe JongDepartment of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea
P-349The Hidden Diagnostic Burden of Spontaneous Intracranial Hypotension: Insight into Extensive Imaging Studies and Specialty Visits Prior to DiagnosisHabibi, ParnianMayo Clinic
P-350Daily light exposure habits of youth with migraine: A prospective pilot studyPatterson Gentile, CarlynChildrens Hospital of Philadelphia
P-351Interaction of Gender, Psychiatric Comorbidities, and Insurance Type in Headache Frequency: Data from the 2019 NHIS DatasetLee, JennyUCLA Medical Center
P-352Differential Impact of Migraine with and without Aura on Severe Maternal Morbidity and Postpartum Readmissions: Insights from a National Cohort StudyTram, MichelleAlbany Medical College
P-353OnabotulinumtoxinA Injections for Chronic Migraine Management During Pregnancy: A Retrospective Chart ReviewMadu, TheandraThe Hospital of the University of Pennsylvania
P-354Open Burn Pit Exposure in Airborne Hazards and Open Burn Pit (AH&OBP) Registry Participants with Cluster HeadacheSchindler, EmmanuelleVA Connecticut Healthcare System
P-355High Comorbidity between Endometriosis and Migraine: A Comprehensive Meta-AnalysisWoldeamanuel, Yohannes WoubishetMayo Clinic Arizona
P-356The Migraine Clinical Outcome Assessment System (MiCOAS) measures: Physical FunctioningHouts, CarrieVector Psychometric Group, LLC
P-357The Migraine Clinical Outcome Assessment System (MiCOAS) measures: Social FunctioningHouts, CarrieVector Psychometric Group, LLC
P-358Daytime fasting of 5-6 hours is associated with same-day headache in adults with episodic migraineSlavin, MargaretUniversity of Maryland, College Park
P-359Majority of Alabama youth with migraine lack access to acute treatment when at schoolTurner, ScottUAB
P-360Global Economic Burden of Migraine: A Meta-Analysis of 116 Studies Estimating $9896 Per Person Per Year and 1.9% of GDP in 2025.Woldeamanuel, Yohannes WoubishetMayo Clinic Arizona
P-361The Migraine Clinical Outcome Assessment System (MiCOAS) measures: Cognitive FunctioningHouts, CarrieVector Psychometric Group, LLC
P-362Survey on Trends and Perceptions of Women’s Neurology Training Among Neurology Residents and Program DirectorsNandyala, ArathiWeill Cornell Medicine
P-363AI-Powered Question Bank: Transforming Headache Boards Preparation In Headache MedicineDave, JayMount Sinai
P-364Building a National Headache Medicine Research Network: The BE WELL with Migraine Champion Providers Network™Wells, RebeccaAtrium Health Wake Forest Baptist
P-365Using a Community-Engaged Based Approach to Develop a Text Messaging Intervention to Enhance Self-management Behaviors in African Americans with MigraineCharleston, LarryCharleston Health Neurology & Head Pain Consultants
P-366Occipital Nerve Stimulation Modulates Cortical Activity in a Rodent Model of MigraineMuthuswamy, JitArizona State University, Tempe
P-367Characterization of Electrophysiological Properties of Trigeminal Ganglion Neurons That Innervate the Maxillary Sinus in MiceStatusGupta, SauravUniversity of Alabama at Birmingham
P-368A Methodological Framework for Machine Learning-Based Migraine Prediction: Integrating Blood Oxygen Saturation and Barometric Pressure in a Simulated StudyBaker, ElizabethUniversity of Louisville
P-369Predictors of Therapeutic Response in Idiopathic Intracranial Hypertension: A Systematic Review and Meta-AnalysisYu, FangWestchester Medical Center
P-370Effectiveness and Safety of Repetitive Intravenous Chlorpromazine Infusions in Pediatric Patients with Refractory Headache Disorders: A Retrospective Chart Review StudyShapiro, HannahUniversity of California, San Francisco
P-371Evaluation of Anti-CGRP Medications for the Prevention of Migraines in Pediatric PatientsConaway, AlyssaUniversity of Iowa Health Care
P-372Acute Severe Hyponatremia During Treatment with Intravenous Lidocaine Infusion in a Patient with Chronic MigraineAhmed, NabilMidwestern University
P-373Iron deposition in periaqueductal gray matter for migraine and medication-overuse headache: an observational study based on quantitative susceptibility mappingLiu, KaimingThe Second Affiliated Hospital, Zhejiang University School of Medicine